Scholarlink

<p>Current therapeutic strategies for Parkinson’s disease (PD) focus exclusively on symptomatic management without addressing underlying disease progression. Despite decades of research emphasizing the enhancement of the cellular defense pathway, disease-modifying treatments remain elusive. We evaluated rotating magnetic field (RMF) therapy in A53T transgenic mice harboring a familial PD-associated mutation. Transgenic and wild-type animals (<i>n</i> = 8 per group) received RMF treatment (4&#xa0;Hz, 0.4 T, 2&#xa0;h daily) for six months. Motor function, muscle strength, and neuropathological markers were assessed. Comprehensive transcriptomic and proteomic analyses were performed to elucidate the molecular mechanisms involved. Untreated A53T transgenic mice exhibited progressive motor decline (51% reduction in locomotor activity, 39% decrease in muscle strength) accompanied by the accumulation of pathological α-synuclein aggregates. RMF-treated transgenic mice demonstrated significant functional recovery, with 78% wild-type locomotor activity and 80% normal muscle strength, with a marked reduction in α-synuclein pathology. Molecular profiling revealed unexpected suppression of hyperactivated stress response pathways, including mTOR signaling, autophagy, and oxidative stress responses (NES = –2.05 to –2.65, FDR &lt; 0.01), whereas metabolic defense mechanisms such as glutathione biosynthesis were increased (NES = 2.18, FDR &lt; 0.001).These findings suggest that normalization of aberrant stress signaling through RMF therapy represents a novel disease-modifying strategy with potential applicability to other neurodegenerative disorders characterized by proteostasis dysfunction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rotating Magnetic Field Therapy Induces System-Level Neuroprotection in A53T α-Synuclein Transgenic Mice Through Coordinated Suppression of Cellular Stress Pathways

  • 期刊论文

  • 发表日期：

    2026年2月17日

查看全文
  • Umer Anayyat,
  • Muhammad Naeem Kiani,
  • Xueying Mei,
  • Fen Zhang,
  • Aliza Fatima,
  • Zhuohang Yang,
  • Kan Li,
  • Guangsen Zheng,
  • Yunpeng Wei,
  • Xiaomei Wang

摘要

Current therapeutic strategies for Parkinson’s disease (PD) focus exclusively on symptomatic management without addressing underlying disease progression. Despite decades of research emphasizing the enhancement of the cellular defense pathway, disease-modifying treatments remain elusive. We evaluated rotating magnetic field (RMF) therapy in A53T transgenic mice harboring a familial PD-associated mutation. Transgenic and wild-type animals (n = 8 per group) received RMF treatment (4 Hz, 0.4 T, 2 h daily) for six months. Motor function, muscle strength, and neuropathological markers were assessed. Comprehensive transcriptomic and proteomic analyses were performed to elucidate the molecular mechanisms involved. Untreated A53T transgenic mice exhibited progressive motor decline (51% reduction in locomotor activity, 39% decrease in muscle strength) accompanied by the accumulation of pathological α-synuclein aggregates. RMF-treated transgenic mice demonstrated significant functional recovery, with 78% wild-type locomotor activity and 80% normal muscle strength, with a marked reduction in α-synuclein pathology. Molecular profiling revealed unexpected suppression of hyperactivated stress response pathways, including mTOR signaling, autophagy, and oxidative stress responses (NES = –2.05 to –2.65, FDR < 0.01), whereas metabolic defense mechanisms such as glutathione biosynthesis were increased (NES = 2.18, FDR < 0.001).These findings suggest that normalization of aberrant stress signaling through RMF therapy represents a novel disease-modifying strategy with potential applicability to other neurodegenerative disorders characterized by proteostasis dysfunction.